| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2006 | US20060204551 Synergistic salivation agents |
| 09/14/2006 | US20060204550 Food and beverages containing L-carnitine derivatives |
| 09/14/2006 | US20060204548 Microimplants for ocular administration |
| 09/14/2006 | US20060204547 Drug delivery stent with extended in vivo release of anti-inflammatory |
| 09/14/2006 | US20060204543 Semirigid implant of glycolic acid-lactic acid copolymer with hydroxypropylmethyl cellulose as release modifier for cyclosporine; biodegradation; sustained release |
| 09/14/2006 | US20060204537 Silicone blends and composites for drug delivery |
| 09/14/2006 | US20060204530 Benzoyl peroxide compositions and methods of use |
| 09/14/2006 | US20060204526 Emulsive composition containing Dapsone |
| 09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 09/14/2006 | US20060204505 Methods for identifying tumors responsive to treatment with HER dimerization inhibitors (HDIs) |
| 09/14/2006 | US20060204504 Reducing leakage from unwanted choroidal neovasculature by administering an anti-FasL factor to permit an effective amount to localize in the neovasculature, administering a photosensitizer to the neovasculature, and irradiating it with laser light; photodynamic therapy |
| 09/14/2006 | US20060204502 Enhancing treatment of cancer and HIF-1 mediated disorders with adenosine A3 receptor antagonists |
| 09/14/2006 | US20060204486 combination therapy of flibanserin with an antipsychotic drug |
| 09/14/2006 | US20060204481 Methods of promoting cell viability |
| 09/14/2006 | US20060204478 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/14/2006 | US20060204474 Treatment of epithelial layer lesions |
| 09/14/2006 | US20060204472 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 09/14/2006 | US20060204471 Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging |
| 09/14/2006 | US20060204466 Hydroalcoholic antimicrobial composition with skin health benefits |
| 09/14/2006 | US20060204459 Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases |
| 09/14/2006 | US20060204450 Pharmaceutical Compositions Based On Anticholinergics and PDE 5-Inhibitors |
| 09/14/2006 | US20060204449 Nasal pharmaceutical composition of piribedil |
| 09/14/2006 | US20060204448 Powdery preparation for nasal administration |
| 09/14/2006 | US20060204447 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
| 09/14/2006 | US20060204446 Topical immunotherapy and compositions for use therein |
| 09/14/2006 | US20060204444 Protein cages for the delivery of medical imaging and therapeutic agents |
| 09/14/2006 | US20060204443 Methods for tumor treatment using dendrimer conjugates |
| 09/14/2006 | US20060204441 Cell scaffold matrices with incorporated therapeutic agents |
| 09/14/2006 | US20060204440 Radio-opaque polymeric biomaterials |
| 09/14/2006 | US20060204437 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 09/14/2006 | US20060201379 Applying paint, protective coating of Medetomidine which adsorbs strongly to metal nanoparticles; improves the performance of antifouling paints |
| 09/14/2006 | US20060201212 End cover assembly for a hollow structural member |
| 09/14/2006 | DE19922287B4 Verwendung von Flavonoidestern in Kosmetika Use of Flavonoidestern in cosmetics |
| 09/14/2006 | DE102006006115A1 New quinoxaline derivatives useful e.g. in cosmetic and pharmaceutical preparation as photo stable UV-filter with reduced skin penetration potential to protect human skin or hair against sun radiation |
| 09/14/2006 | DE102005011058A1 Substituierte Tetrahydro-pyrrolo-chinolinderivate Substituted tetrahydro-pyrrolo-quinoline derivatives |
| 09/14/2006 | DE102005010770A1 Producing 1,4-diphenylazetidinone derivatives useful as cholesterol resorption inhibitors from protected beta-substituted amino amides comprises using a quaternary phosphonium salt catalyst |
| 09/14/2006 | DE102005010255A1 Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung Fibre-free transdermal therapeutic system and process for its preparation |
| 09/14/2006 | DE102005009194A1 Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid A process for producing polymorphic stable triamcinolone acetonide |
| 09/14/2006 | CA2745782A1 Pharmaceutical compositions and uses for peptide treatment |
| 09/14/2006 | CA2640120A1 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo(3.1.0) hexanes |
| 09/14/2006 | CA2604071A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 09/14/2006 | CA2602010A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 09/14/2006 | CA2601980A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | CA2601978A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/14/2006 | CA2601279A1 Formulation for aviptadil |
| 09/14/2006 | CA2601028A1 Flavonoid compounds and uses thereof |
| 09/14/2006 | CA2600886A1 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 09/14/2006 | CA2600675A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 09/14/2006 | CA2600640A1 39-desmethoxy derivatives of rapamycin |
| 09/14/2006 | CA2600638A1 Composition comprising emodepside and praziquantel or epsiprantel |
| 09/14/2006 | CA2600637A1 Tetrahydro- and dihydroquinazolinones |
| 09/14/2006 | CA2600636A1 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 09/14/2006 | CA2600630A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators |
| 09/14/2006 | CA2600623A1 Azithromycin powder for oral suspension compositions |
| 09/14/2006 | CA2600608A1 Composition comprising human igg2 antibody and chelating agent |
| 09/14/2006 | CA2600558A1 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane |
| 09/14/2006 | CA2600475A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 09/14/2006 | CA2600429A1 Treatment with statin and omega-3 fatty acids and a combination product thereof |
| 09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
| 09/14/2006 | CA2600358A1 Method for treatment of hepatic cancer |
| 09/14/2006 | CA2600350A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 09/14/2006 | CA2600339A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | CA2600276A1 Polyphenol coxib combinations and methods |
| 09/14/2006 | CA2600254A1 Benzoxazocines and their therapeutic use |
| 09/14/2006 | CA2600178A1 Novel method for obtaining a fast-dissolving imidapril powder |
| 09/14/2006 | CA2600169A1 Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2600134A1 Methods and compositions for treating cancer |
| 09/14/2006 | CA2600085A1 Microparticle and pharmaceutical preparation |
| 09/14/2006 | CA2600067A1 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues 6 |
| 09/14/2006 | CA2600064A1 Treatment of amyotrophic lateral sclerosis with norethindrone and anal0gues6 |
| 09/14/2006 | CA2600039A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 09/14/2006 | CA2600035A1 Combination of a silicon containing component and a hormone |
| 09/14/2006 | CA2600025A1 The use of thiophosphonoformic acid and nrtis to treat viral infections |
| 09/14/2006 | CA2599974A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2599968A1 Topical gels compositions |
| 09/14/2006 | CA2599937A1 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | CA2599872A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | CA2599783A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
| 09/14/2006 | CA2599778A1 Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases |
| 09/14/2006 | CA2599758A1 Pharmaceutical compositions comprising sirolimus and/or an analogue thereof |
| 09/14/2006 | CA2599721A1 Pharmaceutical compositions for the treatment and/or prevention of depression |
| 09/14/2006 | CA2599699A1 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/14/2006 | CA2599547A1 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 09/14/2006 | CA2599511A1 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | CA2599376A1 Roflumilast for the treatment of diabetes mellitus |
| 09/14/2006 | CA2599368A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | CA2599290A1 Ketoprofen sis adhesive for skin adhesive plaster |
| 09/14/2006 | CA2599252A1 Carnitine-containing peritoneal dialysis solution having improved biocompatibility |
| 09/14/2006 | CA2599251A1 Microemulsions of cannabinoid receptor binding compounds |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | CA2599186A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists |
| 09/14/2006 | CA2599125A1 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 09/14/2006 | CA2598899A1 Novel hsp90 inhibitor |
| 09/14/2006 | CA2598861A1 Organic compounds |
| 09/14/2006 | CA2598613A1 Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors |
| 09/14/2006 | CA2598530A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 09/14/2006 | CA2598527A1 Ophthalmic uses of s1p receptor modulators |